3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP salvage SBRT - Prostatic Neoplasm | Phase 2 | Unknown | Regina Elena Cancer Institute | 103 | 2022-09-27 | 2022-12-28 |
| HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapy - Prostatic Neoplasm | Phase 2 | Unknown | David Büchser | 50 | 2019-07-01 | 2020-08-24 |
| An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma Docetaxel, Androgen-Deprivation Therapy (ADT) - Prostatic Neoplasm | Phase 2 | Unknown | Samsung Medical Center | 42 | 2017-02-08 | 2022-03-08 |
Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Prostatic Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3)
Androgen Antagonists (1) · Docetaxel (1)
David Büchser (1) · Regina Elena Cancer Institute (1) · Samsung Medical Center (1)
Italy (1) · South Korea (1) · Spain (1)